FDA Inspection 1311806 — Tom van Meerten, MD, PhD

Tom van Meerten, MD, PhD — FEI 3020933328

The FDA completed an inspection of Tom van Meerten, MD, PhD on March 27, 2026 in Groningen. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.